Professional Documents
Culture Documents
SUN
Yes
XXNo
Full Name
&
Residential
Address of
Placee
Number of
Securities
Purchased
or to be
Purchased
Ken Kawa
PO Box 118
Creighton, SK
S0P 0A0
100,000
Barry Daniels
2806-1128 Alberni St.
Vancouver, BC
V6E 4R6
50,000
Purchase
Conversion
price per
Price (if
Security
Applicable)
(CDN$)
Prospectus
Exemption
No. of
Securities,
Describe
directly or
Payment relations
indirectly,
Date(1) -hip to
Owned,
Issuer (2)
Controlled or
Directed
$0.10
n/a
NI45-106
s. 2.3
104,000
Payment
on
Unrelated
delivery of
shares
$0.10
n/a
NI45-106
s. 2.5
96,000
February Friend of
17, 2015 Director
$0.10
n/a
NI45-106
s. 2.3
50,000
December
Unrelated
22, 2014
50,000
Dwight Bishop
100 Orchard Avenue
Wolfville, NS
B4P 2J3
Darby Investments Inc.
1780 400 Burrard
Street
Vancouver, BC
V6C 3A6
Brenda T. Yamanaka
law Corporation
3228 Woodland Drive
Vancouver, BC
V5N 3R4
Ricky Williams
3194 Turner Street
Vancouver, BC
V5K 2H1
Steve Jeske
1100 595 Burrard
Street
Vancouver, BC
V7X 1C4
50,000
$0.10
n/a
NI45-106
s. 2.3
50,000
50,000
n/a
NI45-106
s. 2.5
50,000
$0.10
n/a
NI45-106
s. 2.5
150,000
$0.10
n/a
NI45-106
s. 2.5
200,000
Business
December
associate of
22, 2014
Director
$0.10
n/a
NI45-106
s. 2.3
90,000
Payment
on
Unrelateed
delivery of
shares
$0.10
n/a
NI45-106
s. 2.5
525,000
Business
November
associate of
1, 2014
Director
50,000
Mark Koch
7671 Harley Drive
Lantzville, BC
V0R 2H0
525,000
TOTAL
1,125,000
Held in
lawyers
trust
Friend of
account
Director
upon
delivery of
shares
Held in
lawyers
trust
Friend of
account
Director
upon
delivery of
shares
$0.10
50,000
200,000
January
Unrelated
15, 2015
$112,500
(1) Indicate date each placee advanced or is expected to advance payment for securities. Provide
details of expected payment date, conditions to release of funds etc. Indicate if the placement funds
been placed in trust pending receipt of all necessary approvals.
(2) Indicate if Related Person.
1
An issuance of non-convertible debt does not have to be reported unless it is a significant transaction as defined in
Policy 7, in which case it is to be reported on Form 10.
1.
2.
Provide full details of the use of the proceeds. The disclosure should be
sufficiently complete to enable a reader to appreciate the significance of the
transaction without reference to any other material.
The proceeds shall be used by the Company for working capital .
3.
4.
5.
6.
(a)
Class Common .
(b)
Number 1,125,000 .
(c)
(d)
Number 1,125,000 .
(b)
7.
8.
9.
(c)
Exercise price$0.15 .
(d)
(b)
Maturity date
(c)
Interest rate
(d)
Conversion terms
(e)
Default provisions
Provide the following information for any agents fee, commission, bonus or
finders fee, or other compensation paid or to be paid in connection with the
placement (including warrants, options, etc.):
(a)
(b)
Cash
(c)
Securities
(d)
Other
(e)
(f)
State whether the sales agent, broker, dealer or other person receiving
compensation in connection with the placement is Related Person or has any
other relationship with the Issuer and provide details of the relationship
.
10.
Describe any unusual particulars of the transaction (i.e. tax flow through
shares, etc.).
None .
FORM 9 NOTICE OF PROPOSED ISSUANCE OF
LISTED SECURITIES
November 14 2008
Page 4
11.
12.
Where there is a change in the control of the Issuer resulting from the
issuance of the private placement shares, indicate the names of the new
controlling shareholders.
.
13.
2.
Acquisition
1. Provide details of the assets to be acquired by the Issuer (including the location of
the assets, if applicable). The disclosure should be sufficiently complete to
enable a reader to appreciate the significance of the transaction without
reference to any other material: N/A .
2. Provide details of the acquisition including the date, parties to and type of agreement
(eg: sale, option, license etc.) and relationship to the Issuer. The disclosure
should be sufficiently complete to enable a reader to appreciate the
significance of the acquisition without reference to any other material:
3.
Provide the following information in relation to the total consideration for the
acquisition (including details of all cash, securities or other consideration) and
any required work commitments:
(a)
(b)
Cash:
(c)
(d)
Other:
(e)
(f)
(g)
Work commitments:
4.
State how the purchase or sale price was determined (e.g. arms-length
negotiation, independent committee of the Board, third party valuation etc).
5.
6.
Name of
Party (If not
an
individual,
name all
insiders of
the Party)
Number
and Type
of
Securities
to be
Issued
Dollar
value per
Security
(CDN$)
Conversion
price (if
applicable)
Prospectus
Exemption
No. of
Securities,
directly or
indirectly,
Owned,
Controlled or
Directed by
Party
Describe
relationship
to Issuer (1)
7.
Details of the steps taken by the Issuer to ensure that the vendor has good
title to the assets being acquired:
.
8.
Provide the following information for any agents fee, commission, bonus or
finders fee, or other compensation paid or to be paid in connection with the
acquisition (including warrants, options, etc.):
(a)
(b)
Cash
(c)
Securities
(d)
Other
(e)
(f)
9.
State whether the sales agent, broker or other person receiving compensation
in connection with the acquisition is a Related Person or has any other
relationship with the Issuer and provide details of the relationship.
10.
Certificate Of Compliance
The undersigned hereby certifies that:
1.
The undersigned is a director and/or senior officer of the Issuer and has been
duly authorized by a resolution of the board of directors of the Issuer to sign
this Certificate of Compliance on behalf of the Issuer.
2.
As of the date hereof there is not material information concerning the Issuer
which has not been publicly disclosed.
3.
4.